Stay updated on Teclistamab Dose Escalation Study in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Teclistamab Dose Escalation Study in Multiple Myeloma Clinical Trial page.

Latest updates to the Teclistamab Dose Escalation Study in Multiple Myeloma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedFooter area updated to Revision: v3.3.3; the HHS Vulnerability Disclosure link and the previous Revision: v3.3.2 reference were removed.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedA new version entry (82) with a Study Status update was added to the history page, reflecting routine record-keeping. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check41 days agoChange DetectedRevision label updated from v3.2.0 to v3.3.2 at the bottom of the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check48 days agoChange DetectedVersion 81 was added on 2025-11-07 reflecting an updated Study Status. A government funding lapse notice from 2025-10-10 was removed.SummaryDifference0.5%

- Check63 days agoChange DetectedNew history entries have been added to the Record History page, reflecting updated submission dates and ongoing record-keeping. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check84 days agoChange DetectedThe page now includes a new date entry and a note about study status/design, while an older date is removed; core content and critical details remain unchanged.SummaryDifference0.9%

Stay in the know with updates to Teclistamab Dose Escalation Study in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Teclistamab Dose Escalation Study in Multiple Myeloma Clinical Trial page.